DRUG GUIDELINE

Octreotide (Intravenous Bleeding Oesophageal Varices)

SCOPE (Area): Emergency, Operating Suite, Critical Care Unit, General Wards, (Exclude: Paediatrics Seek Advice)

SCOPE (Staff): Medical, Nursing, Pharmacy

Printed versions of this document SHOULD NOT be considered up to date / current

Paediatrics (seek Paediatrician advice)

See Appendix 1 for full version of this Drug Guideline!

	AZCERT Inc. (2013). Octreotide. CredibleMeds. Retrieved Jun 12, 2019, from https://crediblemeds.org
	Drug Infusion Preparation Guide for Emergency Department and Critical Care Unit â€“ Octreotide.
	IBM Corporation. (2019). IBM Micromedex. Retrieved March 28, 2019, from https://www.micromedexsolutions.com/home/dispatch/ssl/true
	Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved March 28, 2019, from http://www.amh.net.au/online/view.php
	The Society of Hospital Pharmacists of Australia. (2019, May 23). Australian Injectable Drugs Handbook (7th ed.), Octreotide acetate. Retrieved June 12, 2019, from https://aidh.hcn.com.au/browse/about_aidh
	Therapeutic Guidelines Limited. (2019, April). Gastrointestinal Guidelines. Retrieved March 28, 2019, from http://online.tg.org.au/ip/.
	UBM Medica. (2019, May). MIMS Online, DBL Octreotide InjectionÂ® product information. Retrieved March 28, 2019, from https://www.mimsonline.com.au/Search/Search.aspx
	UBM Medica. (2019, May). MIMS Online, SandostatinÂ® product information. Retrieved March 28, 2019, from https://www.mimsonline.com.au/Search/Search.aspx
	UpToDate, Inc. (2019) UpToDate, Drug Interaction section. Retrieved March 28, 2019, from https://www.uptodate.com/contents/search

Reg Authority: Medication Safety & Governance Committee (MSGC)	Date Effective: 04/03/2020
Review Responsibility: Pharmacist - Rotational	Date for Review: 30/09/2024

Octreotide (Intravenous Bleeding Oesophageal Varices) - DRG0029 - Version: 4 - (Generated On: 30-04-2025 06:00)